Platinum Chemotherapy Hypersensitivity Prevalence and Management
被引:46
|
作者:
Otani, Iris M.
论文数: 0引用数: 0
h-index: 0
机构:
UCSF Med Ctr, Div Pulm Crit Care Allergy & Sleep Med, Dept Med, 400 Parnassus Ave,Fifth Floor, San Francisco, CA 94143 USAUCSF Med Ctr, Div Pulm Crit Care Allergy & Sleep Med, Dept Med, 400 Parnassus Ave,Fifth Floor, San Francisco, CA 94143 USA
Otani, Iris M.
[1
]
Wong, Johnson
论文数: 0引用数: 0
h-index: 0
机构:
Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Med, 55 Fruit St, Boston, MA 02114 USAUCSF Med Ctr, Div Pulm Crit Care Allergy & Sleep Med, Dept Med, 400 Parnassus Ave,Fifth Floor, San Francisco, CA 94143 USA
Wong, Johnson
[2
]
Banerji, Aleena
论文数: 0引用数: 0
h-index: 0
机构:
Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Med, 55 Fruit St, Boston, MA 02114 USAUCSF Med Ctr, Div Pulm Crit Care Allergy & Sleep Med, Dept Med, 400 Parnassus Ave,Fifth Floor, San Francisco, CA 94143 USA
Banerji, Aleena
[2
]
机构:
[1] UCSF Med Ctr, Div Pulm Crit Care Allergy & Sleep Med, Dept Med, 400 Parnassus Ave,Fifth Floor, San Francisco, CA 94143 USA
[2] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Med, 55 Fruit St, Boston, MA 02114 USA
Hypersensitivity reactions to platinum agents are common. For carboplatin and cisplatin, the first hypersensitivity reaction typically occurs around the second and third re-exposure during the second line of therapy (eighth and ninth courses overall). For oxaliplatin, the first hypersensitivity reaction can occur throughout the treatment course. Skin testing helps risk stratify patients to appropriate desensitization protocols and assess risk for breakthrough HSRs during desensitization. A risk-stratification protocol using 3 serial skin tests and desensitization protocols enables patients with platinum agent hypersensitivity to receive first-line chemotherapy treatment safely.
机构:
Iuliu Hatieganu Univ Med & Pharm, Dept Res Dev & Innovat, Cluj Napoca, RomaniaIuliu Hatieganu Univ Med & Pharm, Dept Res Dev & Innovat, Cluj Napoca, Romania
Havasi, Andrei
Crisan, Cristina
论文数: 0引用数: 0
h-index: 0
机构:
Prof Dr Ion Chiricuta Inst Oncol, Cluj Napoca 400015, RomaniaIuliu Hatieganu Univ Med & Pharm, Dept Res Dev & Innovat, Cluj Napoca, Romania
Crisan, Cristina
Heputiu-Pater, Ana Teodora
论文数: 0引用数: 0
h-index: 0
机构:
Dr Gavril Curteanu Municipal Clin Hosp, Oradea, RomaniaIuliu Hatieganu Univ Med & Pharm, Dept Res Dev & Innovat, Cluj Napoca, Romania
Heputiu-Pater, Ana Teodora
Bochis, Ovidiu-Vasile
论文数: 0引用数: 0
h-index: 0
机构:
Prof Dr Ion Chiricuta Inst Oncol, Cluj Napoca 400015, RomaniaIuliu Hatieganu Univ Med & Pharm, Dept Res Dev & Innovat, Cluj Napoca, Romania
Bochis, Ovidiu-Vasile
Cainap, Calin
论文数: 0引用数: 0
h-index: 0
机构:
Prof Dr Ion Chiricuta Inst Oncol, Cluj Napoca 400015, Romania
Iuliu Hatieganu Univ Med & Pharm, Dept Oncol, Cluj Napoca, RomaniaIuliu Hatieganu Univ Med & Pharm, Dept Res Dev & Innovat, Cluj Napoca, Romania
Cainap, Calin
Crisan, Ovidiu
论文数: 0引用数: 0
h-index: 0
机构:
Iuliu Hatieganu Univ Med & Pharm, Fac Pharm, Cluj Napoca, RomaniaIuliu Hatieganu Univ Med & Pharm, Dept Res Dev & Innovat, Cluj Napoca, Romania
Crisan, Ovidiu
Balacescu, Ovidiu
论文数: 0引用数: 0
h-index: 0
机构:
Prof Dr Ion Chiricuta Inst Oncol, Cluj Napoca 400015, RomaniaIuliu Hatieganu Univ Med & Pharm, Dept Res Dev & Innovat, Cluj Napoca, Romania
Balacescu, Ovidiu
Balacescu, Loredana
论文数: 0引用数: 0
h-index: 0
机构:
Prof Dr Ion Chiricuta Inst Oncol, Cluj Napoca 400015, RomaniaIuliu Hatieganu Univ Med & Pharm, Dept Res Dev & Innovat, Cluj Napoca, Romania
Balacescu, Loredana
Cainap, Simona
论文数: 0引用数: 0
h-index: 0
机构:
Iuliu Hatieganu Univ Med & Pharm, Dept Mother & Child, Cluj Napoca, Romania
Emergency Pediat Clin Hosp, Dept Pediat, Cluj Napoca, RomaniaIuliu Hatieganu Univ Med & Pharm, Dept Res Dev & Innovat, Cluj Napoca, Romania